Latest News - Cencora
Top Corporates Hub
Cencora
Can CAH's Specialty Flywheel Strategy Unlock Long-Term Growth?
01.04.2026 14:27
CAH's specialty flywheel strategy links distribution, MSOs and biopharma services, boosting partnerships, drug launches and recurring revenue potential.
1 Large-Cap Stock for Long-Term Investors and 2 We Avoid
31.03.2026 10:21
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
Is It Time To Reassess Cencora (COR) After The Recent Share Price Pullback?
31.03.2026 05:03
Investors may be wondering whether Cencora is attractively priced after its recent run and pullback, or if the stock is now reflecting too much optimism. The share price closed at US$309.93, with a 3.3% decline over the last 7 days and a 16.7% decline over the last 30 days. This is set against a 12.2% return over 1 year and very strong returns over 3 and 5 years. Recent coverage has focused on Cencora as a key healthcare distributor and supply chain player, with attention on how it fits into...
Cencora, Inc. (COR) Signs Binding Agreement to Expand Retina Network With EyeSouth Acquisition
30.03.2026 11:39
We recently compiled a list of the 13 Best Stocks to Invest In on Robinhood for Beginners. Cencora, Inc. is the next best Robinhood stock on this list. TheFly reported on March 23 that COR revealed that it has signed a binding agreement to acquire the retina division of EyeSouth Partners for $1.1 billion. Once the […]
Reflecting On Health Insurance Providers Stocks’ Q4 Earnings: Cencora (NYSE:COR)
26.03.2026 14:57
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at health insurance providers stocks, starting with Cencora (NYSE:COR).
Why STAAR Surgical (STAA) Stock Is Trading Up Today
25.03.2026 02:34
Shares of medical lens company STAAR Surgical (NASDAQ:STAA) jumped 3.7% in the afternoon session after investors reacted to positive news in the broader ophthalmology sector as Cencora agreed to acquire EyeSouth Partners' retina business for $1.1 billion.
COR to Expand Retina Consultants of America With $1.1B EyeSouth Deal
24.03.2026 14:21
Cencora is acquiring EyeSouth's retina business for $1.1 billion, expanding its RCA platform to strengthen foothold in the fast-growing eye care market.
Kultura Brands (OTC:LTNC) Accelerates National Momentum With Cencora Marketplace Spring & Summer Growth Acceleration Program
24.03.2026 12:15
JACKSON, WY / ACCESS Newswire / March 24, 2026 / Kultura Brands Inc., formerly known as Labor Smart INC. (OTCID:LTNC), a rapidly emerging platform focused on high-growth beverage and functional wellness brands, today announced its expanded participation ...
Cencora to buy EyeSouth’s retina business for $1.1B
24.03.2026 09:19
The proposed acquisition is Cencora’s latest push into retina services as the company looks to expand its specialty support business. Cencora doesn't expect the deal to close before the end of September.
Cencora to Acquire EyeSouth Partners' Retina Business in $1.1 Billion Deal
23.03.2026 13:39
Cencora (COR) said Monday that it will acquire EyeSouth Partners' retina business for $1.1 billion a
Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business
23.03.2026 11:00
CONSHOHOCKEN, Pa., March 23, 2026--Cencora, Inc. (NYSE: COR) today announced the signing of a definitive agreement to acquire EyeSouth Partners’ retina business for $1.1 billion. Upon completion of the transaction, the affiliated retina physicians of EyeSouth Partners will join Cencora’s Retina Consultants of America ("RCA"), a leading management services organization (MSO).
Cencora Agrees To Acquire EyeSouth Partners' Retina Business For $1.1B
23.03.2026 07:11
Cencora, Inc. (NYSE:COR) today announced the signing of a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion. Upon completion of the transaction, the affiliated retina physicians of
Here’s Why Cencora (COR) Shares Rose 8% in Q4
20.03.2026 13:25
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned -3.55% (gross) and -3.76% (net) in the fourth quarter compared to a -3.70% return for the Russell Midcap Growth Index. In 2025, the strategy returned 14.84% […]
CENCORA INC (NYSE:COR) Passes the "Caviar Cruise" Quality Investing Screen
18.03.2026 12:01
Discover Cencora Inc., a quality investment example with strong growth, high capital returns, and solid cash flow in healthcare distribution.
1 Healthcare Stock with Exciting Potential and 2 We Ignore
18.03.2026 11:13
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 3.6% over the past six months, topping the S&P 500 by 2.3 percentage points.
Tuesday's session: gap up and gap down stock in the S&P500 index
17.03.2026 15:35
Tuesday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Cencora Announces Financial Leadership Transition
17.03.2026 12:30
CONSHOHOCKEN, Pa., March 17, 2026--Cencora, Inc. (NYSE: COR) today announced that James F. Cleary will retire as Executive Vice President and Chief Financial Officer effective June 30, 2026. Cencora has engaged an executive search firm to identify and evaluate potential successors from internal and external candidates. Mr. Cleary will assist in the search process and will serve in an advisory capacity through the end of 2026 to help ensure a smooth transition.
Cencora CFO announces retirement
17.03.2026 09:32
James Cleary will step down from the post on June 30, but stay on as an adviser to the company through the end of the year. He’s the second finance chief of a drug distributor to announce their retirement this month.
How Cardinal Health, The IBD Stock Of The Day, Is Navigating The Tricky Macro
13.03.2026 17:07
Cardinal Health is Friday's IBD Stock Of The Day. Shares are in a buy zone as the medical wholesaler easily navigates macro challenges.